MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 152 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,953 | -12.2% | 75 | +38.9% | 0.00% | – |
| Q2 2023 | $12,474 | +267.7% | 54 | +285.7% | 0.00% | – |
| Q1 2023 | $3,392 | -16.5% | 14 | 0.0% | 0.00% | – |
| Q4 2022 | $4,064 | – | 14 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 14 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 14 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 14 | -30.0% | 0.00% | – |
| Q4 2021 | $3,000 | +50.0% | 20 | +5.3% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 19 | -5.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 20 | -9.1% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 22 | +10.0% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 20 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 20 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | – | 20 | +42.9% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 14 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 14 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 14 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 14 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 14 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -99.3% | 14 | -99.0% | 0.00% | – |
| Q3 2018 | $293,000 | -24.3% | 1,371 | -1.1% | 0.00% | – |
| Q2 2018 | $387,000 | +73.5% | 1,386 | -27.2% | 0.00% | – |
| Q1 2018 | $223,000 | – | 1,905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |